The placenta's innermost layer, the amniotic membrane, is made up of tissue and cells that serve as a wound-healing mechanism for the regeneration of soft tissue. As biologically active cells are present in the epithelial and stromal layers of the amniotic membrane and release growth factors and cytokines with anti-inflammatory, anti-immunogenic, and anti-fibrotic properties, these amniotic membranes are used in eye surgery for healing and replacing the damaged eye tissues.
DataM Intelligence reports can help you make the right business decisions. It is an analysis of the market and industry, which helps in understanding the market better. This report will provide you with all the information you need to know about this sector so that it becomes easy for you to make informed decisions.
Our market research reports offer a comprehensive overview of this sector and its dynamics. We have done extensive research on this topic and are confident that our findings will be helpful for anyone who needs some guidance or direction when making important decisions related to their company’s future growth strategy.
Ophthalmology Amniotic Membrane Market size was valued at USD 403.6 million in 2022 and is estimated to reach a CAGR of 9.80% over the forecast period 2023-2030.
Market Dynamics:
Incidents of Burn Injuries are Driving the Market
Because burn wounds are becoming more common, there is a large growth in the need for wound care biologics, particularly amniotic membranes. According to the WHO, the majority of burn incidents take place in low- and middle-income countries, with nearly two-thirds of those occurrences taking place in the WHO areas of Africa and Southeast Asia.
Risks Involved with the Usage Restrict the Market:
Since there's minimal risk, amniotic membranes should be treated carefully. The patient or amniotic membrane recipient may get bacterial, viral, or fungal illnesses from unscreened donors. The patient or receiver may be at risk if the membrane is treated or stored outside of sterile conditions. Gram-positive isolates are most common after amniotic membrane transplantation, with incidence rates of 1.6% to 8.0%. Repetitive transplantations may cause early amniotic membrane degradation and cheese wiring, which is concerning.
Market Key Players:
The global ophthalmology amniotic membrane market is highly competitive with the presence of several domestic and international players.
- FzioMed, Inc.
- Amniox Medical, Inc.
- Derma Sciences
Companies are following new product launches, product diversification, and market expansion strategies to increase their market penetration.
The Bottom Line:
To better understand the global ophthalmology amniotic membrane market, its opportunities, and challenges, we invite you to request a sample report from DataM Intelligence. This comprehensive report will provide valuable insights into the market dynamics, helping business decision-makers, investors, CXOs, and R&D professionals make informed decisions in this rapidly evolving industry.
To Explore More Download Sample
